Acumen Pharmaceuticals (ABOS) Debt Ratio (2023 - 2026)

Acumen Pharmaceuticals has disclosed Debt Ratio across 4 years of filings, most recently posting 0.44 for Q2 2026.

• In Q2 2026, Debt Ratio rose 154.1% year-over-year to 0.44; the TTM figure through Jun 2026 stood at 0.44 (up 154.1% YoY), while the FY2025 annual figure was 0.33, up 164.06% from the prior year.
• Debt Ratio came in at 0.44 for Q2 2026 at Acumen Pharmaceuticals, up from 0.34 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.44 in Q2 2026 to a low of 0.1 in Q4 2023.
• Average Debt Ratio over 4 years is 0.2, with a median of 0.14 recorded in 2025.
• Year-over-year, Debt Ratio grew 27.69% in 2024 and soared 164.06% in 2025.
• Over 4 years, Debt Ratio stood at 0.1 in 2023, then increased by 27.69% to 0.12 in 2024, then soared by 164.06% to 0.33 in 2025, then surged by 35.89% to 0.44 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.44 in Q2 2026, 0.34 in Q1 2026, and 0.33 in Q4 2025.